Frontiers in Immunology Tomaszewska, A, Jagasia, M, Beohou, E, van der Werf, S, Blaise, D, Kanfer, E, Milpied, N, Reményi, P, Ciceri, F, Bourhis, J H, Chevallier, P, Solano, C, Socié, G, Bruno, B, Rambaldi, A, Castagna, L, Kröger, N, Corradini, P, Afanasyev, B, Ladetto, M, Niederwieser, D, Scheid, C, Sengeloev, H, Kroschinsky, F, Yakoub-Agha, I, Schoemans, H, Koenecke, C, Penack, O, Perić, Z, Greinix, H, Duarte, R F & Basak, G W 2021, ' Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes : EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies ', Frontiers in Immunology, vol. 11, 613954 . https://doi.org/10.3389/fimmu.2020.613954 Frontiers in Immunology, Vol 11 (2021) r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname